![]() Marine Corps component commanders and surgeons shall coordinate with supporting Military Treatment Facilities (MTFs) to ensure operational forces and training commands receive priority administration from Influenza vaccine shipments. Operational forces and training commands are prioritized for receipt of Influenza vaccine by the Department of the Navy. If personnel require vaccination with both hemisphere vaccines, administration should be separated by a minimum of 30 days.ģ.c. Marine Corps personnel shall receive the seasonal Southern Hemisphere (SH) Influenza vaccine if they will be assigned more than 14 days in the SH Influenza zone between 1 Apr 23 and 30 Sep 23 (see ref (c), appendix (5), for a list of applicable countries). Per encl (3) of ref (c), Marine Corps personnel shall receive the seasonal NH Influenza vaccine if they will be assigned, permanently or temporarily, more than 14 days in the NH Influenza zone between 1 Oct 23 and 30 Mar 24. The Marine Corps reserve component shall vaccinate at least 90 percent of required personnel no later than the DoD goal of 15 Jan 24.ģ.b. The Marine Corps active component shall ensure 100 percent of personnel are compliant with DoD policy (vaccinated or approved medical or administrative exemption) no later than 15 Dec 23. Per refs (a), (b), and (c), all Marine Corps active and reserve component personnel shall receive the 2023-2024 seasonal Influenza vaccine(s) unless medically or administratively exempt. Maximum vaccination of the force reduces transmission of disease, and reduces severity of disease in personnel who become infected.ģ.a. A timely comprehensive vaccination program must be enforced by Marine Corps leadership in order to mitigate risk to force and risk to mission. Seasonal Influenza is a highly contagious disease that has the potential to significantly impact force health and mission readiness. Provide guidance to Marine Corps active and reserve components to implement the 2023-2024 Northern and Southern Hemisphere Influenza Vaccination Program.Ģ. POC/DRISCOLL, SEAN/CDR/HQMC/HS/DIRECTOR OF PUBLIC HEALTH/TEL: 70/ EMAIL: FRANCISPAUL/HM1/HQMC/HS/MRRS COORDINATOR/TEL: 70/ EMAIL: Purpose. REF G IS THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) RECOMMENDATIONS FOR 2023-2024 INFLUENZA SEASON.// REF F IS THE CIVILIAN HEALTH AND MEDICAL PROGRAM OF THE UNIFORMED SERVICES (CHAMPUS)/TRICARE: TRICARE PHARMACY BENEFITS PROGRAM. REF E IS OPNAVINST 3710.7V, NAVAL AIR TRAINING AND OPERATING PROCEDURES STANDARDIZATION GENERAL FLIGHT AND OPERATING INSTRUCTIONS. REF D IS MARADMIN 631/10, REQUIREMENT TO TRACK AND IMPROVE INDIVIDUAL MEDICAL READINESS FOR ACTIVE AND RESERVE COMPONENTS. REF C IS DEFENSE HEALTH AGENCY (DHA) PROCEDURAL INSTRUCTION 6025.34, GUIDANCE FOR THE DOD INFLUENZA VACCINATION PROGRAM. REF B IS BUMEDINST 6230.15B, IMMUNIZATIONS AND CHEMOPROPHYLAXIS FOR THE PREVENTION OF INFECTIOUS DISEASES. NARR/REF A IS DODINST 6205.02, DOD IMMUNIZATION PROGRAM. ![]() REF/G/DOC/CDC/MMWR RECOMMENDATIONS AND REPORTS NO. REF/D/GENADMIN/CMC WASHINGTON DC PP0/051110ZNOV10// REF/A/DOC/USD P&R WASHINGTON DC/23JUL19// SUBJ/2023-24 INFLUENZA VACCINE GUIDANCE FOR ACTIVE AND RESERVE COMPONENTS//
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |